This randomized trial compares the efficacy of targeted complicated grief treatment, citalopram, both, or neither on the outcomes of patients with complicated grief.
This meta-analysis examines baseline depression severity as a moderator of treatment outcomes between cognitive behavioral therapy and antidepressant medication.
This Viewpoint discusses the use of fibroblast growth factor 2 as an adjunct for treating anxiety.
This open-label pharmacological trial uses group-based trajectory modeling to assess patterns of response to extended-release venlafaxine for late-life depression in older adults and the clinical factors associated with these patterns.
This national survey describes the limited effectiveness of an abuse-deterrent formulation of OxyContin and residual abuse among patients in drug treatment programs.
Huhn et al perform a systematic overview on the efficacy of pharmacotherapies and psychotherapies for major psychiatric disorders and compare the quality of pharmacotherapy and psychotherapy trials. See also the editorial by Correll and Carbon.
Wallace et al demonstrate a novel exploratory approach to moderation analysis with a sample of 291 adults from a randomized clinical trial that compared an empirically supported psychotherapy and selective serotonin reuptake inhibitor pharmacotherapy as treatments for depression.
Humphreys and coauthors meta-analyze the longitudinal association between treatment with stimulant medication during childhood and later substance use disorders.